Third Harmonic Bio, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 30.82 million compared to USD 35.16 million a year ago. Basic loss per share from continuing operations was USD 0.78 compared to USD 2.45 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.3 USD | +4.33% | +6.13% | +12.12% |
Mar. 28 | Third Harmonic Bio, Inc. Appoints Geoff Mcdonough to Its Board of Directors | CI |
Mar. 26 | Third Harmonic Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.12% | 481M | |
+2.97% | 108B | |
+10.21% | 105B | |
+1.57% | 23.46B | |
-12.77% | 21.72B | |
-7.05% | 18.64B | |
-37.64% | 17.45B | |
-6.50% | 17.19B | |
+6.00% | 13.99B | |
+37.20% | 12.53B |
- Stock Market
- Equities
- THRD Stock
- News Third Harmonic Bio, Inc.
- Third Harmonic Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023